DEPower
exploratoryplatform · medium · Thu Feb 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Make rigorous RNA-seq study design and sample size determination accessible for single-cell and bulk RNA-seq experiments.
Web-based approximate power analysis tool grounded in the DESeq2 model framework.
bioRxiv preprint published in 2026 describing the DEPower tool and availability at https://poweranalysis-fb.streamlit.app/.
Derives analytical sample size requirements for RNA-seq experiments using assumptions aligned with DESeq2.
Fauna Brain AI Platform
undisclosedplatform · high · Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Accelerate target discovery and early-stage drug discovery using animal genomics from resilient species.
AI-powered platform evolved from Fauna Bio's Convergence discovery engine, using proprietary disease-resistance datasets and human genomics integration.
Official launch announced on June 16, 2025.
Reported as already delivering promising early-stage R&D outputs, but no specific targets or efficacy results are provided in the supplied material.
Cardio-pulmonary disorders therapeutic compositions
preclinicaldrug program · medium · Thu Apr 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Develop methods and compositions for treating cardio-pulmonary disorders.
Patent-disclosed chemical compositions and treatment methods; specific intervention details are not available in the supplied excerpt.
PCT patent application WO2025077825A1 published on 2025-04-17 and listed as pending.
Convergence AI Discovery Platform
undisclosedplatform · high · Fri Dec 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Identify therapeutic targets by modeling how extreme animal species resist disease and translating those mechanisms to human drug discovery.
Comparative genomics, proprietary mammalian biobank data, machine learning, and human genomics integration.
Applied in a multi-year Eli Lilly obesity preclinical drug discovery collaboration announced in December 2023.
ADAPT
undisclosedresearch program · medium
Undisclosed Fauna Bio pipeline program listed by the company.
Not disclosed in the supplied material.
Listed on Fauna Bio's pipeline page.
ASCRIPTS
undisclosedresearch program · medium
Undisclosed Fauna Bio pipeline program listed by the company.
Not disclosed in the supplied material.
Listed on Fauna Bio's pipeline page.
Convergence AI Platform
undisclosedplatform · high
Replicate mechanisms by which extreme animal models resist disease to identify therapeutic targets and create human drugs.
AI drug discovery platform using an exclusive biobank of genetic data, comparative genomics, animal disease-resistance datasets, and integration with human genomics.
Used in a multi-year Eli Lilly obesity discovery collaboration announced in December 2023; later described as the predecessor to Fauna Brain.
No specific platform validation results are provided in the supplied material.
DEPower RNA-seq power analysis tool
exploratoryother · high
Make rigorous RNA-seq study design accessible by estimating sample-size requirements for single-cell and bulk RNA-seq experiments.
Web-based analytical power analysis tool grounded in the DESeq2 model framework.
bioRxiv preprint published in 2026 with tool available at https://poweranalysis-fb.streamlit.app/.
The supplied abstract states that DEPower derives sample size requirements for single-cell and bulk RNA-seq experiments using DESeq2 assumptions.
Eli Lilly obesity discovery collaboration
preclinicaldrug program · high
Discover preclinical therapeutic targets for obesity using Fauna Bio's AI platform.
Application of the Convergence AI platform for preclinical drug discovery in obesity under a multi-year collaboration with Eli Lilly.
Multi-year $494M agreement with Eli Lilly announced in December 2023.
Eli Lilly Obesity Discovery Collaboration
preclinicaldrug program · high
Identify multiple drug targets focused on obesity using Fauna Bio's AI-enabled comparative genomics and disease-resistance platform.
Preclinical target discovery collaboration applying Fauna's Convergence AI platform to obesity biology.
First target designation announced in the ongoing obesity discovery collaboration; original multi-year agreement with Eli Lilly announced in December 2023 for up to $494 million in milestones plus royalties.
At least one target designation is reported, but target identity and experimental results are not disclosed in the supplied material.
Project ADAPT
exploratoryresearch program · high
Study hibernation in space and evaluate clinical applications for space travel and human hibernation, including hibernation-related protection from spaceflight stressors.
NASA Innovative Advanced Concepts-funded research program studying hibernation biology in a space context.
Fauna Bio researcher awarded a NASA early-stage grant on January 22, 2024 to study hibernation in space.
No study results are provided in the supplied material.
Project RADIANCE
exploratoryresearch program · high
Study the protective effects of hibernation against radiation exposure.
Multi-space-agency-supported long-term study of hibernation-associated radiation protection; described as formerly Project ASCRIPTS.
Listed on Fauna Bio's site as a long-term study, formerly Project ASCRIPTS, with initial funding from the Space Radiation program referenced in the supplied excerpt.
No results are provided in the supplied material.
Project STASH
exploratoryresearch program · low
Listed as a Fauna Bio pipeline program; objectives are not described in the supplied material.
Not disclosed in the supplied material.
Listed in Fauna Bio's pipeline.
RADIANCE
undisclosedresearch program · medium
Undisclosed Fauna Bio pipeline program listed by the company; supplied company description links Fauna Bio to space-focused research including radiation protection.
Not disclosed in the supplied material.
Listed on Fauna Bio's pipeline page.
Space-focused metabolism, muscle loss, bone loss, hibernation, and radiation protection research
exploratoryresearch program · medium
Study space-related biology relevant to metabolism, muscle loss, bone loss, hibernation, and radiation protection.
Research programs using Fauna Bio's animal-model and AI-driven discovery approach; specific methods are not disclosed in the supplied material.
Identified in supplied site analysis as active space-focused research programs.
STASH
undisclosedresearch program · medium
Undisclosed Fauna Bio pipeline program listed by the company.
Not disclosed in the supplied material.
Listed on Fauna Bio's pipeline page.
